Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps?. An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen

Maturitas

Volumn 54, Issue 3, 2006, Pages 252-259

  McGurgan, P ^a   Taylor, L J ^b   Duffy, S R ^b   O'Donovan, P J ^a  

^a BRADFORD ROYAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Bcl 2; Endometrial polyps; Ki67; Oestrogen; Postmenopausal; Progesterone; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; TAMOXIFEN; TAMOXIFEN CITRATE;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIUM POLYP; FEMALE; HUMAN; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; POLYPECTOMY; POSTMENOPAUSE; PROTEIN EXPRESSION; RANK SUM TEST; TREATMENT DURATION;

AGED; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POLYPS; POSTMENOPAUSE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TAMOXIFEN;

EID: 33646540443     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.11.007     Document Type: Article

References (26)

1. Fox H., and Buckley H. Uterine pathology. In: Fox H., and Buckley H. (Eds). Gynaecological and obstetric pathology for the MRCOG (1998), RCOG Press, London 55-57
2. McGurgan P., O'Donovan P., and Duffy S. How should we manage endometrial polyps?. The yearbook of obstetrics and gynaecology (2002), RCOG Press, London p. 348-57
3. Van Bogaert L.J. Clinicopathologic findings in endometrial polyps. Obstet Gynecol 71 5 (1988) 771-773
4. Reslova T., Tosner J., Resl M., Kugler R., and Vavrova I. Endometrial polyps. A clinical study of 245 cases. Arch Gynecol Obstet 262 3-4 (1999) 133-1339
5. Jaiyesimi I.A., and Budzar A.U. Use of tamoxifen for breast cancer: 28 years later. J Clin Oncol 13 2 (1995) 513-529
6. Gorodeski G.I., and Beery R. Tamoxifen increases plasma oestrogen binding equivalents and has an oestradiol agonistic effect on histologically normal pre-menopausal and post-menopausal endometrium. Fertil Steril 57 2 (1992) 320-327
7. De Muldyer X., and Neven P. Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Obstet 36 (1991) 127
8. Gerdes J., Schwab U., Lemke H., and Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31 (1983) 13-20
9. Elias J.M. Cell proliferation indexes: a biomarker in solid tumours. Biotech Histochem 72 2 (1996) 78-85
10. Bakhshi A., Jensen J.P., Goldman P., et al. Cloning the chromosomal breakpoint of t(14;18) human lymphoma: clustering around chromosome 14 and near a transcriptional unit on 18. Cell 41 (1985) 889-906
11. Vinatier D., Dufour P., and Subtil D. Apoptosis: a programmed cell death involved in ovarian and uterine physiology. Eur J Obstet Gynaecol Reprod Biol 67 (1996) 85-102
12. Taylor L.J., Jackson T.L., Reid J.G., and Duffy S.R. The differential expression of ER, PR, Bcl-2 and Ki67 in endometrial polyps. Br J Obstet Gynaecol 110 9 (2003) 794-798
13. Ravn V., Havsteen H., and Thorpe S. Immunohistochemical evaluation of estrogen and progesterone receptors in paraffin embedded formalin fixed endometrial tissues: comparison with enzyme immunoassay and immunohistochemical analysis of frozen tissue. Mod Pathol 11 8 (1998) 709-715
14. Thijs I., Neven P., Van Hooff I., et al. Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium. Eur J Cancer 36 (2000) S93-S118
15. Maia H., Maltez A., Calmon L., Oliveira M., Marques D., and Coutinho E. Histopathology and steroid receptors in endometrial polyps of postmenopausal patients under hormone replacement therapy. Gynae Endosc 7 (1998) 267-272
16. Maia H., Maltez A., Athayde C., and Coutinho E. Proliferation profile of endometrial polyps in postmenopausal women. Maturitas 40 (2001) 273-281
17. Pickartz H., Beckmann R., Fleige B., Gerdes J., and Stein H. Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria. Virchows Arch A: Pathol Anat 417 (1990) 163-171
18. Risberg B., Karlsson K., Abeler V., Lagrelius A., Davidson B., and Karlsson M. Dissociated expression of Bcl-2 and ki-67 in endometrial lesions: diagnostic and histogenetic implications. Int J Gynecol Pathol 21 (2002) 155-160
19. Cohen I., Beyth Y., Altaras M.M., et al. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens. Gynecol Oncol 65 (1997) 83-88
20. Cohen I., Beyth Y., Altaras M.M., et al. Estrogen and progesterone receptor expression in postmenopausal tamoxifen exposed endometrial pathologies. Gynecol Oncol 67 (1997) 8-15
21. Schwartz L., Krey L., Demopoulos R., Goldstein S.R., Nachtigall L.E., and Mittal K. Alterations in the steroid hormone receptors in the tamoxifen treated endometrium. Am J Obstet Gynecol 176 (1997) 129-137
22. Jamil A., Croxtall J.D., and White J.O. The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cell lines (Ishikawa). J Mol Endocrinol 6 (1991) 215-221
23. Vering A., Vockel A., Stegmuller M., and Bender H.G. Immunobiochemical assay for determination of nuclear steroid receptors during tamoxifen therapy. J Cancer Res Clin Oncol 119 (1993) 415-420
24. Classen- Linke I., Alfer J., Hey S., Krusche C.A., Krusche M., and Beier H.M. Marker molecules of human endometrial differentiation can be hormonally regulated under in-vitro conditions as in-vivo. Hum Reprod Update 4 5 (1998) 539-549
25. Snijders M.P., De Goeij A.F., and Koudstaal J. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium. J Pathol 166 (1992) 171-177
26. Otsuki Y., Misaki O., Sugimoto O., Ito Y., Tsujimoto Y., and Akao Y. Cyclic Bcl-2 expression in human uterine endometrium during menstrual cycle. Lancet 344 (1994) 28-29